Windtree Therapeutics, Inc.
WINT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $14 | $4,479 |
| - Cash | $204 | $301 | $1,173 | $1,779 |
| + Debt | $3,374 | $8,693 | $1,579 | $1,822 |
| Enterprise Value | $3,172 | $8,395 | $420 | $4,522 |
| Revenue | $0 | $0 | $0 | $90 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$17 | -$17 | $45 |
| % Margin | – | – | – | 50% |
| EBITDA | $0 | -$10,535 | -$4,008 | $2,769 |
| % Margin | – | – | – | 3,076.7% |
| Net Income | -$28,938 | -$10,640 | -$4,045 | $2,767 |
| % Margin | – | – | – | 3,074.4% |
| EPS Diluted | -1.08 | -3.06 | -4.63 | 0.27 |
| % Growth | 64.7% | 33.9% | -1,814.8% | – |
| Operating Cash Flow | -$6,372 | -$2,657 | -$2,407 | -$3,685 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6,372 | -$2,657 | -$2,407 | -$3,685 |